McCormick & Company stock climbed roughly 3% in premarket activity on Thursday, trading at $48.13, after the flavor and spice maker exceeded expectations in its second quarter of fiscal 2026.
The company recorded net sales of $1.94 billion for the quarter, a 16.7% increase year on year, and posted non-GAAP earnings of $0.80 per share - a result that was 14.8% above analysts' consensus estimates. Management also reiterated its fiscal 2026 adjusted EPS guidance of $3.05 to $3.13; the midpoint of $3.09 aligns with the analyst consensus.
Several line items in the report helped underpin the upbeat market reaction. Net sales growth of 16.7% included a 2.7% tailwind from favorable currency movements, while organic sales advanced 1.7%. Reported operating income for the quarter was $276 million, versus $246 million in the year-ago period. On an adjusted basis, operating income rose to $336 million from $259 million a year earlier.
The company announced a quarterly dividend of $0.48 per share, payable July 20, 2026, continuing a 102-year run of consecutive dividend payments. That dividend announcement accompanied the operational and financial details that investors digested ahead of the open.
McCormick's results arrived against a mixed market backdrop. Broad indices were uneven in the session: the S&P 500 slipped 0.1%, the Nasdaq fell 0.4%, and the Dow Jones inched up 0.4%, reflecting a generally cautious tone in equities overall.
Brokerage sentiment heading into the report showed differing views. JP Morgan maintained an Overweight rating and a $63 price target, while UBS retained a Neutral rating with a $51 target. Both targets are substantially above the current trading level and underscore how far shares remain from their 52-week high of $77.65.
Management and investors still face known headwinds cited by the company, including elevated commodity costs and investor concerns related to the pending acquisition of Unilever's food business. Taken together with the quarter's results, the combination of a clear earnings and revenue beat, modest organic growth, and a reaffirmed full-year outlook provided investors with an identifiable rationale to push McCormick shares higher in an otherwise subdued session.
The stronger-than-expected quarter helped extend the stock's recovery from its 52-week low of $44.30. Despite that recovery, the shares continue to trade at a meaningful discount to their 52-week high, leaving the potential for further re-rating if the company continues to deliver on integration and growth execution.
Key takeaways:
- McCormick beat expectations on revenue and adjusted EPS for Q2 fiscal 2026, with sales of $1.94 billion and non-GAAP EPS of $0.80.
- The company reaffirmed fiscal 2026 adjusted EPS guidance of $3.05 to $3.13, with the midpoint matching analyst consensus at $3.09.
- Net sales growth included a 2.7% favorable currency effect, organic sales rose 1.7%, and adjusted operating income increased to $336 million.
Risks and uncertainties:
- Persistent elevated commodity costs remain a headwind for margins and are a risk to future profitability.
- Investor concerns about the pending Unilever food business acquisition introduce uncertainty around execution and integration.
- Shares trade well below the 52-week high, indicating market skepticism that could limit upside absent continued execution.
This article presents the quarter's results and market context without projecting outcomes beyond the facts disclosed in the report and commentary above.